Healthcare IT Today January 23, 2023
Healthcare IT News

New company advances precision health through data-driven solutions

New company Velsera was announced today at the J.P. Morgan Healthcare Conference in San Francisco, California. The vision for Velsera is supported by thematic-focused impact fund Summa Equity (Summa).

The promise of precision medicine is held back by barriers across routine health practice and discovery. Existing companies offer partial solutions, but no single company enables the unlocking of insights waiting to be revealed inside data – the status quo is siloed and disconnected. Velsera enables the democratization of omic data across clinical and research applications.

Velsera transforms science, technology, and informatics into an ecosystem of insight, making data actionable through the integration of a rich software platform, deep domain expertise, and knowledge...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Conferences / Podcast, Pharma / Biotech, Precision Medicine, Trends
23andMe: What If …
23andMe CEO Anne Wojcicki considers taking company private
Age of Opportunity: Artificial Intelligence and the Precision Medicine Future
Opinion: Readers respond to OTC antidepressants, personalized medicine, restoring trust in public health, and more
Precision medicine approach combining AI, DNA and drug testing shows gains against relapsed childhood cancers

Share This Article